Charlotte Fribert

Company: Toleranzia

Job title: Chief Executive Officer

Seminars:

Targeting Myasthenia Gravis with Antigen-Specific Immune Tolerance Approaches for a Durable, Disease Modifying Treatment 10:40 am

• Inducing immune tolerance in MG disease patients with a nanoparticle-based immune tolerizing therapy encapsulating gliadin proteins • Delving into the design of clinical trials for efficacy – considering the interplay of accurate disease modeling and good standard of care with administering a tolerizing therapy • Assessing the durability and necessary dosage to induce immune…Read more

day: Conference Day One